Can low-molecular-weight heparin improve the outcome of patients with operable non-small cell lung cancer? - An urgent call for research

被引：19

作者：

Alifano, M

Benedetti, G

Trisolini, R

机构：

[1] Osped Maggiore Bologna, Chirurg Torac, I-40100 Bologna, Italy

[2] Maggiore Bellaria Hosp, Med Oncol Unit, Bologna, Italy

[3] Maggiore Bellaria Hosp, Unit Thorac Endoscopy, Bologna, Italy

来源：

CHEST | 2004年 / 126卷 / 02期

关键词：

low-molecular-weight heparin; lung cancer; outcome; recurrence; surgery;

D O I：

10.1378/chest.126.2.601

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：601 / 607

页数：7

共 74 条

[41]

MANNORI G, 1995, CANCER RES, V55, P4425

[42]

Miao HQ, 1999, INT J CANCER, V83, P424, DOI 10.1002/(SICI)1097-0215(19991029)83:3<424::AID-IJC20>3.0.CO

[43]

2-L

[44] Heparin inhibits Ca2+/calmodulin-dependent kinase II activation and c-fos induction in mesangial cells [J].

Miralem, T ;

Templeton, DM .

BIOCHEMICAL JOURNAL, 1998, 330 :651-657

[45]

Monreal M, 2000, Curr Opin Pulm Med, V6, P326, DOI 10.1097/00063198-200007000-00013

[46] Revisions in the International System for Staging Lung Cancer [J].

Mountain, CF .

CHEST, 1997, 111 (06) :1710-1717

[47]

Nieswandt B, 1999, CANCER RES, V59, P1295

[48] Survival and prognostic factors of surgically resected T4 non-small cell lung cancer [J].

Osaki, T ;

Sugio, K ;

Hanagiri, T ;

Takenoyama, M ;

Yamashita, T ;

Sugaya, M ;

Yasuda, M ;

Yasumoto, K .

ANNALS OF THORACIC SURGERY, 2003, 75 (06) :1745-1751

[49]

Parish CR, 1999, CANCER RES, V59, P3433

[50] EVIDENCE THAT SULFATED POLYSACCHARIDES INHIBIT TUMOR-METASTASIS BY BLOCKING TUMOR-CELL-DERIVED HEPARANASES [J].

PARISH, CR ;

COOMBE, DR ;

JAKOBSEN, KB ;

BENNETT, FA ;

UNDERWOOD, PA .

INTERNATIONAL JOURNAL OF CANCER, 1987, 40 (04) :511-518

← 1 2 3 4 5 6 7 8 →